Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
mafenidacetat 85 mg/g, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
mafenidacetat 5 %, pulver för beredning av injektionsvätska |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
sulfacetamid 10 %, lösning |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely sulconazole nitrate 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
butenafinhydroklorid 1 %, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
haloprogin 1 %, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Haloprogin 10 mg/mL cutaneous solution |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
oxikonazolnitrat 1 %, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
oxikonazolnitrat 1 %, lösning |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
kliokinol 3 % + hydrokortison 0,5 %, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
naftifinhydroklorid 1 %, gel |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
jodokinol 1 % + hydrokortison 1 %, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely metronidazole 7.5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
skopolamin 0,5 mg/24 timmar, plåster |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely glyceryl trinitrate 200 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely glyceryl trinitrate 300 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
nitroglycerin 0,6 mg/h |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
nitroglycerin 0,1 mg/h |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
nitroglycerin 0,2 mg/h |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
nitroglycerin 0,4 mg/h |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
alitretinoin 0,1 %, gel |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
monobenzon 20 %, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely methoxsalen 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Hexachlorophene 30 mg/mL cutaneous emulsion |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely Podophyllum resin 250 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
metoxsalen 20 mcg/ml, injektionsvätska, lösning, flaska 10 ml |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Methoxsalen 10mg/mL lotion |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
kantaridin 0,7 %, vätska |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
nitroglycerin 0,2 mg/h, runt depåplåster |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
nitroglycerin 0,3 mg/h, depåplåster |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
nitroglycerin 0,4 mg/h, depåplåster |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
skopolamin 1,5 mg/enhet, plåster |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
hexaklorofen 3 %, tvål |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely becaplermin 100 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
halobetasolpropionat 0,05 %, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
halobetasolpropionat 0,05 %, salva |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely chloroxine 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
podofilox 0,5 %, gel |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Glyceryl trinitrate 800 microgram/hour prolonged-release transdermal patch |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely glyceryl trinitrate 400 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely glyceryl trinitrate 600 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely amphotericin B 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely lidocaine hydrochloride 30 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
mafenidacetat 112 mg, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
mafenidacetat 5 %, pulver |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
betametasonvalerat 0,12 %, aerosol |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Amphotericin B 30 mg/mL cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
naftifinhydroklorid 1 %, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Amcinonide 1 mg/mL cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
diflorasondiacetat 0,5 mg, salva |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely diflorasone diacetate 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
gentamicinsulfat 1 %, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
gentamicinsulfat 0,1 %, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Calcipotriene hydrate 0.005% cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
klindamycinfosfat 10 milligram/milliliter, kutan lösning |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
fludroxikortid 4 mikrogram, plåster |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Fludroxycortide 500 microgram/mL cutaneous lotion |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
hydrokinon 30 mg, lösning |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely hydroquinone 30 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
hydrokinon 4 %, gel |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Anthralin 0.25% topical cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Hydrocortisone valerate 2 mg/g cutaneous ointment |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone valerate 2 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
betametasondipropionat 0,05 %, lotion |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
betametasondipropionat 0,05 %, gel |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 4% solution |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
betametasondipropionat 0,5 mg/g, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
betametasondipropionat 0,5 mg/g, salva |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
klonidin 2,5 mg/enhet |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
betametasondipropionat 0,5 mg, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
betametasondipropionat 0,5 %, salva |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
bensoylperoxid 10 % |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Triamcinolone acetonide 1 mg/g cutaneous ointment |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Triamcinolone acetonide 250 microgram/mL cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely triamcinolone acetonide 5 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
hydrokortisonacetat 30 mg |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
bensoylperoxid 4 %, lösning |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
bensoylperoxid 3 %, gel |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
bensoylperoxid 4 %, gel |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
bensoylperoxid 8 %, gel |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
bensoylperoxid 8 %, lösning |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
bensoylperoxid 8 %, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
bensoylperoxid 10 %, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
bensoylperoxid 5 %, sköljvätska för lokalt bruk |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
bensoylperoxid 6 %, gel |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
adapalen 0,1 %, lösning |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Tretinoin 1 mg/g cutaneous gel |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely tretinoin 200 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Tretinoin 1 mg/mL cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Calcipotriene 0.005% solution |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Calcipotriene 0.005% ointment |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
dexametason 10 mg/25 mg |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Nystatin 100 unit/mg cutaneous powder |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Fluocinonide 500 microgram/g cutaneous gel |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely fluocinonide 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Desonide 500 microgram/mL cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely desonide 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Desonide 500 microgram/g cutaneous ointment |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|